Risk factors for severe respiratory syncytial virus lower respiratory tract infection - Wikidata - awgldk - TriplyDB

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

http://www.wikidata.org/entity/Q40412523

about

The use of antibiotics for preventing lower respiratory tract infections in at risk children less than 12 years old Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis The Danish National Prescription Registry in studies of a biological pharmaceutical: palivizumab - validation against two external data sources.Risk Factors for Hospitalization due to Lower Respiratory Tract Infection in Preterm Infants on Palivizumab Prophylaxis A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.Respiratory syncytial virus infections in infants affected by primary immunodeficiency.Exposure to infections and risk of leukemia in young children.Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact Respiratory syncytial virus-associated hospitalizations in pre-mature infants in Lima, Peru Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review.Evaluation of IgG Antibodies Against Respiratory Syncytial Virus (RSV), and Associated Risk Factors for Severe Respiratory Tract Infections in Pre-School Children in North-Central, Nigeria.Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection.Risk factors for bronchiolitis hospitalization during the first year of life in a multicenter Italian birth cohort.Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).Safely Discharging Infants with Bronchiolitis from an Emergency Department: A Five Step Guide for Pediatricians.A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS).Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma.The prevalence and risk factors of allergic and respiratory symptoms in a regional cohort of extremely low birth weight children (<1000 g)Trend of invasive pneumococal disease (IPD) in a South Western, Nigerian hospital Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe.Vaccination against RSV: is maternal vaccination a good alternative to other approaches?Strategic priorities for respiratory syncytial virus (RSV) vaccine development.Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity.First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005-2015).Role of Parental Smoking in Severe Bronchiolitis: A Hospital Based Case-Control Study.Human respiratory syncytial virus memphis 37 causes acute respiratory disease in perinatal lamb lung.Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory-syncytial-virus-related infection in cystic fibrosis children less than 2 years of age?A review of cost-effectiveness of palivizumab for respiratory syncytial virus.Use of palivizumab in infants and young children with severe respiratory disease: a Delphi study.Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations.Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.The Role of Human Milk Immunomodulators in Protecting Against Viral Bronchiolitis and Development of Chronic Wheezing Illness.Epidemiology of laboratory-confirmed respiratory syncytial virus infection in young children in England, 2010-2014: the importance of birth month.Extraribosomal l13a is a specific innate immune factor for antiviral defense Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis.

P2860

Q24186293-772B6059-26CF-4F60-BA12-FFD17FDF9A50 Q24186994-41234EBF-6A48-4B3F-BC64-FA0A9900C12B Q26830726-C44D33D6-0DB4-4978-82B0-EE1E3053FFD9 Q30244591-6CFEDEBB-9789-4CB6-BEC3-DDB374952676 Q30968297-4EB40786-9528-4F08-8667-3F11D32423CA Q33628327-57793E85-A064-451D-8B8C-DCD1B43EB83D Q33817471-48199A10-C2C0-4590-AF0F-F95796B02F7A Q33892605-184D9744-E448-41B8-B10E-D19EE34DB808 Q33909037-09AFCAA5-E040-43A0-AD43-92025F89E3DE Q34450699-DC7D5FD0-03A9-48CD-AA8F-361DE6F51566 Q34496098-7DD6994C-2760-447C-8D99-3745B88B1C54 Q34726169-3AB6D9B2-D10E-4BC4-99D2-15D9FA4A4A99 Q35075716-40C7B5E9-A949-47FE-9B95-F0ABE48411EF Q35123767-1159DCC4-FD4F-4CAF-A76F-01A312464CDA Q35678345-EB404CB0-2A2D-4F41-B425-1F9529FFC395 Q36054311-C23B9936-88F2-4B80-929C-F7D4FF47F84A Q36149998-32AB90C0-B138-4812-9640-41E5FFE06023 Q36275397-24CB6F58-93BE-4D80-9216-07DF48A1A498 Q36463070-AC1D5851-D864-464A-A20C-A0317F92782E Q36577321-EECBE3E2-2E50-4270-B1C1-9F5C0458ACD7 Q36597211-BB24946A-585F-4F8F-AE3D-FD43A7F44A37 Q36948273-3819F6F6-79BD-4F6F-AE60-0EDBE2854BD0 Q36989863-6E725C05-5FDF-44A5-8A5F-ACA714A20714 Q37056532-81BCA470-1DEE-4256-953D-CC4BBAFCB65D Q37514757-C8268756-B1B9-4909-BAB0-CF855A771FE7 Q37572640-4DB8C4A1-552A-4D87-98F3-DA7791F3C87F Q37596130-F17682B6-B4E9-4E1C-A522-D03A2346A8B8 Q37660572-8EAB3323-F798-4044-A804-61587CEFF51F Q37710217-6D367694-BC56-441F-A919-BB53CDCD01E8 Q37715621-EE16913E-9186-4457-A809-E8B1BB7EB909 Q38057771-04D999ED-CDB7-4684-9C44-1C1182ED98BB Q38058838-A574B8B8-8429-407A-B524-B135D6AB4CF5 Q38115264-AC8F7EA6-7F1E-4724-8D1B-0C52DF8D79C3 Q38198120-9BB33271-2C04-4BBB-990F-DA2E44E5C8BA Q38604949-57A53B8E-BE20-4C01-9015-1241AD86BFD8 Q38671952-48BE0BBC-F907-4D23-AEF1-C3F31E203E56 Q38897076-F4CD91CB-4E14-4F3B-AA32-0F4FE1404210 Q38903197-CEB87DD9-0241-40E9-9365-7FCF873B32D6 Q38988159-5E95B823-69F0-4504-8F1B-FB6CE8910652 Q39025676-B0E5226F-1571-4676-9C69-4221DE36438C

P2860

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

http://www.wikidata.org/entity/Q40412523

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

@en

type

label

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

@en

prefLabel

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

@en

P1433

Q40412523-BF6B1419-EBFE-41C4-9F4E-37361D217201

P1476

Q40412523-CF576F8C-6FC9-4EBE-BEB1-8EC563D2CAE4

P2093

Q40412523-573B1D60-6BD4-4E7A-854A-5956A4B75499

Q40412523-62913191-A11B-4B2E-A2D4-705530B4C598

Q40412523-C9A49FC6-1296-444C-8F28-01F7244C53FE

P2860

Q40412523-03A0849F-C229-4B23-939E-4FFEBAE36347

Q40412523-09E5E7ED-2C0A-407D-961F-EBEC9014AF5F

Q40412523-0E9B215C-340A-424A-9F53-99EEC0FAD074

Q40412523-0F51762A-618D-408B-8002-F0C8BC4666EC

Q40412523-1644D469-7F76-4729-B50E-AF55E0A371E2

Q40412523-1964FCA8-6386-479B-AEDF-75138A4BE675

Q40412523-1BFD9C62-B1B2-4763-9A71-DCDB91E6C157

Q40412523-2B467A05-5706-495B-92B7-6B90B58288DB

Q40412523-2B9C43FB-2F68-4815-A6EF-C0C7D8934410

Q40412523-2C791C7A-E439-4DE6-A782-227E4DCEBED5

P304

Q40412523-BC5C4BE3-FEA2-4E2F-9AA4-D387F6C79C71

P31

Q40412523-BE68B02C-8BA9-4923-BBA8-086C9D9CDA38

P356

Q40412523-06FB7167-76FD-4D35-AE39-861F33E6D81E

P478

Q40412523-F1D3073B-4FBC-4CED-8C78-DE5D89BB8F20

P577

Q40412523-24EC34C5-7EED-4564-9BFE-C095D37B68EA

P5875

Q40412523-1D6051C8-64A9-4B10-95B3-24569C1D83F1

P698

Q40412523-9BE23A81-41BE-4B1B-85DA-3F801F680A91

P932

Q40412523-3B22173D-F80B-40DC-949A-CBFE393C8BAA

P356

1874285801105010144

P1433

The Open Microbiology Journal

P1476

Risk factors for severe respiratory syncytial virus lower respiratory tract infection

@en

P2093

Bernhard Resch

http://www.w3.org/2001/XMLSchema#string

Constanze Sommer

http://www.w3.org/2001/XMLSchema#string

Eric A F Simões

http://www.w3.org/2001/XMLSchema#string

P2860

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.

European risk factors' model to predict hospitalization of premature infants born 33-35 weeks' gestational age with respiratory syncytial virus: validation with Italian data.

Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness

Risk of primary infection and reinfection with respiratory syncytial virus.

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003.

Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection

P304

144-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874285801105010144

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221764491

http://www.w3.org/2001/XMLSchema#string

P698

22262987

http://www.w3.org/2001/XMLSchema#string

P932

3258650

http://www.w3.org/2001/XMLSchema#string